Clinical Trials Directory

Trials / Completed

CompletedNCT02828670

Role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia (TFH in AIHA)

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

T follicular helper (TFH) cells represent a T cell subset dedicated to the activation of B cells. They have been involved in the pathogenesis of autoimmune diseases in humans such as lupus and Sjögren disease. We recently showed that TFH are implicated in the activation of autoreactive B lymphocytes during ITP. Autoimmune hemolytic anemia (AIHA) is an autoimmune disease due to antibodies targeting red blood cells. To date, the role of TFH in the pathogenesis of AIHA is not known. We hypothesize that AIHA is associated with an increase in the number and/or function of TFH, that could participate in the activation of autoreactive B lymphocytes.

Conditions

Interventions

TypeNameDescription
BIOLOGICALblood sample
PROCEDUREspleen sample

Timeline

Start date
2016-06-07
Primary completion
2022-02-15
Completion
2022-02-15
First posted
2016-07-11
Last updated
2024-07-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02828670. Inclusion in this directory is not an endorsement.

Role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia (TFH in AIHA) (NCT02828670) · Clinical Trials Directory